9S5 logo

Fine Foods & Pharmaceuticals N.T.M DB:9S5 Stock Report

Last Price

€7.78

Market Cap

€194.4m

7D

-2.0%

1Y

3.2%

Updated

22 Nov, 2024

Data

Company Financials +

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

DB:9S5 Stock Report

Market Cap: €194.4m

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fine Foods & Pharmaceuticals N.T.M
Historical stock prices
Current Share Price€7.78
52 Week High€9.20
52 Week Low€7.54
Beta0.68
11 Month Change-7.16%
3 Month Change-4.66%
1 Year Change3.18%
33 Year Changen/a
5 Year Changen/a
Change since IPO3.73%

Recent News & Updates

Recent updates

Shareholder Returns

9S5DE Life SciencesDE Market
7D-2.0%-6.1%-1.3%
1Y3.2%2.0%7.4%

Return vs Industry: 9S5 exceeded the German Life Sciences industry which returned 2% over the past year.

Return vs Market: 9S5 underperformed the German Market which returned 7.4% over the past year.

Price Volatility

Is 9S5's price volatile compared to industry and market?
9S5 volatility
9S5 Average Weekly Movement3.4%
Life Sciences Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 9S5 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 9S5's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984780Marco Francesco Eigenmannwww.finefoods.it

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of drugs, food supplements, and other nutraceutical products and medical devices for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders, soluble, effervescent and chewable granules, filmed and effervescent tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatine capsules in various types of packaging, such as sachets, sticks, pillboxes, jars, blisters, tubes, and strips for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company is involved in the production, marketing, research, and development of cosmetics products comprising liquid detergents for personal hygiene, hair care, skin care, bath and shower gels, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, liquid soaps, skin care emulsions, oral hygiene, deodorants, and alcohol-based perfumery products in packaging, including coextruded and laminated tubes, aluminium tubes, special packs, lip sticks, air less, and various bottles and jars under its own and third-party brands.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Fundamentals Summary

How do Fine Foods & Pharmaceuticals N.T.M's earnings and revenue compare to its market cap?
9S5 fundamental statistics
Market cap€194.39m
Earnings (TTM)€4.85m
Revenue (TTM)€243.35m

40.1x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9S5 income statement (TTM)
Revenue€243.35m
Cost of Revenue€167.55m
Gross Profit€75.80m
Other Expenses€70.95m
Earnings€4.85m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.20
Gross Margin31.15%
Net Profit Margin1.99%
Debt/Equity Ratio43.2%

How did 9S5 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

113%

Payout Ratio